Invention Grant
US08148372B2 Metabotropic glutamate receptor isoxazole ligands and their use as potentiators—286
有权
代谢型谷氨酸受体异恶唑配体及其作为增效剂的用途 - 286
- Patent Title: Metabotropic glutamate receptor isoxazole ligands and their use as potentiators—286
- Patent Title (中): 代谢型谷氨酸受体异恶唑配体及其作为增效剂的用途 - 286
-
Application No.: US12860330Application Date: 2010-08-20
-
Publication No.: US08148372B2Publication Date: 2012-04-03
- Inventor: Joseph Cacciola , James Empfield , James Folmer , Angela M Hunter , Scott Throner
- Applicant: Joseph Cacciola , James Empfield , James Folmer , Angela M Hunter , Scott Throner
- Applicant Address: SE Sodertalje
- Assignee: AstraZeneca AB
- Current Assignee: AstraZeneca AB
- Current Assignee Address: SE Sodertalje
- Agent Kenneth F. Mitchell
- Main IPC: A61K31/5377
- IPC: A61K31/5377 ; C07D413/14 ; A61K31/422 ; C07D261/18
Abstract:
Compounds in accord with Formula I: wherein R1, R2, R3 and R4 are as defined in the specification, pharmaceutically acceptable salts, methods of making, pharmaceutical compositions containing and methods for using the same.
Public/Granted literature
- US20100317662A1 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators - 286 Public/Granted day:2010-12-16
Information query
IPC分类:
